摘要
线粒体功能障碍,氧化应激和β-淀粉样蛋白(β)的形成被认为是导致老年痴呆症(AD)的认知能力下降的神经和突触的退化。衰老加速小鼠易发8(SAMP8)小鼠作为动物模型的机理和转化研究,在本研究中我们对线粒体和突触的改变相对SAMR1控制小鼠SAMP8小鼠探索一种小分子肽SS31的保护作用,细胞膜的渗透剂、抗氧剂、线粒体和突触蛋白完整性以及认知能力。电子显微镜分析显示,线粒体和突触恶化在10月龄SAMP8与SAMR1小鼠,在前者的变化治疗8周后获救SS31(5毫克/公斤/天,IP)。Aβ42升高,线粒体分裂蛋白(DLP1,Fis1)和基质蛋白亲环素D(CypD),和线粒体融合蛋白的减少(Mfn2)和突触(即突触,突触后密度蛋白95和生长相关蛋白43)蛋白,检测在SAMP8小鼠海马细胞裂解物相对正常。上述蛋白表达的改变在SAMP8小鼠大脑与SS31处理恢复。此外,在处理学习和检测SS31救出10月龄SAMP8小鼠记忆障碍。这项研究结果表明,这种线粒体靶向抗氧化剂肽可能是用于AD治疗的潜在效用,其药理功效包括降低中枢的一个水平和保护线粒体稳态和突触的完整性,这可能有助于减缓认知能力下降。
关键词: 阿尔茨海默病,淀粉样病变,抗氧化剂,小鼠,线粒体,氧化应激,突触功能。
Current Alzheimer Research
Title:SS31, a Small Molecule Antioxidant Peptide, Attenuates β-Amyloid Elevation, Mitochondrial/Synaptic Deterioration and Cognitive Deficit in SAMP8 Mice
Volume: 13 Issue: 3
Author(s): Yan-Li Jia, Su-Juan Sun, Jing-Hong Chen, Qian Jia, Tian-Tian Huo, Li-Fang Chu, Jiang-Tao Bai, Ye-Jing Yu, Xiao-Xin Yan and Jian-Hua Wang
Affiliation:
关键词: 阿尔茨海默病,淀粉样病变,抗氧化剂,小鼠,线粒体,氧化应激,突触功能。
摘要: Mitochondrial dysfunction, oxidative stress and β -amyloid (Aβ) formation are thought to cause neuronal and synaptic degeneration underlying cognitive decline in Alzheimer’s disease (AD). The senescence-accelerated mouse-prone 8 (SAMP8) mice have been used as an animal model for mechanistic and translational research for AD. In the present study we characterized mitochondrial and synaptic alterations in SAMP8 mice relative to SAMR1control mice and explored a protective effect of the small molecule peptide SS31, a cell membrane penetrant antioxidant, on mitochondrial and synaptic protein integrity as well as cognitive performance. Electron microscopic analysis revealed mitochondrial/synaptic deterioration in 10 months-old SAMP8 relative to SAMR1 mice, with the changes in the former rescued following 8 weeks treatment with SS31 (5 mg/kg/day, i.p.). Elevation of Aβ42, mitochondrial fission protein (DLP1, Fis1) and matrix protein cyclophilin D (CypD), and reductions of mitochondrial fusion protein (Mfn2) and synaptic (i.e. synaptophysin, postsynaptic density protein 95 and growth associated protein 43) proteins, were detected in hippocampal lysates in SAMP8 mice relative to SAMR1. The above altered protein expressions in the SAMP8 mouse brain were restored with the SS31 treatment. Moreover, the SS31 treatment rescued learning and memory deficits detected in 10 month-old SAMP8 mice. Together, the findings suggest that this mitochondria-targeting antioxidant peptide may be of potential utility for AD therapy, with its pharmacological efficacy involves lowering of central Aβ levels and protection of mitochondrial homeostasis and synaptic integrity, which may help slow down cognitive decline.
Export Options
About this article
Cite this article as:
Yan-Li Jia, Su-Juan Sun, Jing-Hong Chen, Qian Jia, Tian-Tian Huo, Li-Fang Chu, Jiang-Tao Bai, Ye-Jing Yu, Xiao-Xin Yan and Jian-Hua Wang , SS31, a Small Molecule Antioxidant Peptide, Attenuates β-Amyloid Elevation, Mitochondrial/Synaptic Deterioration and Cognitive Deficit in SAMP8 Mice, Current Alzheimer Research 2016; 13 (3) . https://dx.doi.org/10.2174/1567205013666151218150004
DOI https://dx.doi.org/10.2174/1567205013666151218150004 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Melatonin having Therapeutic Bone Regenerating Capacity in
Biomaterials
Current Pharmaceutical Biotechnology Pharmacological Interventions and Rehabilitation Approach for Enhancing Brain Self-repair and Stroke Recovery
Current Neuropharmacology Angiogenesis-regulating microRNAs and Ischemic Stroke
Current Vascular Pharmacology Stroke Subtypes and their Possible Implication in Stroke Prevention Drug Strategies
Current Vascular Pharmacology Anesthetic-induced Myocardial Conditioning: Molecular Fundamentals and Scope
Current Medicinal Chemistry Caspases as Drug Targets in Ischemic Organ Injury
Current Drug Targets - Immune, Endocrine & Metabolic Disorders The Complement Cascade: New Avenues in Stroke Therapy
Current Vascular Pharmacology Female Infertility and Antioxidants
Current Women`s Health Reviews Radiological Diagnosis of Renal Thrombosis in Children
Current Pediatric Reviews Diabetes and Antioxidants: Myth or Reality?
Current Vascular Pharmacology Chemokines in Cardiovascular Remodeling: Clinical and Therapeutic Implications
Current Molecular Medicine Gene Therapy: How to Target the Kidney. Promises and Pitfalls
Current Gene Therapy A Mitochondrial Approach to Cardiovascular Risk and Disease
Current Pharmaceutical Design Clinical Applicability of Conditioning Techniques in Ischemia-Reperfusion Injury: A Review of the Literature
Current Cardiology Reviews Polyphenols Beyond Barriers: A Glimpse into the Brain
Current Neuropharmacology Molecular Chaperone ORP150 in ER Stress–related Diseases
Current Pharmaceutical Design The CX3C-Chemokine Fractalkine in Kidney Diseases
Mini-Reviews in Medicinal Chemistry ACE2-Ang-(1-7)-Mas Axis in Brain: A Potential Target for Prevention and Treatment of Ischemic Stroke
Current Neuropharmacology Intravenous Immunoglobulin Preparations and Autoimmune Disorders: Mechanisms of Action
Current Pharmaceutical Biotechnology Identification of Novel Anti-inflammatory Agents from Ayurvedic Medicine for Prevention of Chronic Diseases: “Reverse Pharmacology” and “Bedside to Bench” Approach
Current Drug Targets